Immunostaining experiments conducted on lung tissue demonstrated increased ADAM15 staining in the lungs of patients with COPD versus controls, and localized this staining to macrophages, CD8+ T cells, bronchial and alveolar epithelial cells, and airway α-SMC-positive cells (likely myofibroblasts). This evidence concerns the gene ADAM15 and chronic obstructive pulmonary disease.